GRAIL, Inc. (GRAL) income statement
GRALNasdaqServices-Medical LaboratoriesFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 10/30
$102.10−3.78 (-3.57%)
Close on Nov 18, 2026Market cap $4.56BP/E –Yield –
GRAIL, Inc. income statement
Ratios
Latest available, balances at Jun 30, 2026
Profitability, TTM
- Gross margin
- –
- Operating margin
- -338.4%
- Net margin
- -236.9%
- Return on equity, FY2025
- -16.1%
Financial strength
- Current ratio
- 10.95
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- 66.6%
Valuation
- P/E ratio
- –
- Price to sales
- 27.59
- Price to book
- 1.79
- Dividend yield
- –
See a number that looks wrong?